3/26
08:00 am
npce
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
Low
Report
NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference
3/5
11:36 am
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Cantor Fitzgerald from $19.00 to $20.00. They now have an "overweight" rating on the stock.
Medium
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Cantor Fitzgerald from $19.00 to $20.00. They now have an "overweight" rating on the stock.
3/4
06:13 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
Medium
Report
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/4
04:05 pm
npce
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
Low
Report
NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results
3/3
09:15 pm
npce
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
Medium
Report
UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference
3/3
04:15 pm
npce
NeuroPace to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
Low
Report
NeuroPace to Present at the Leerink Partners Global Healthcare Conference [Yahoo! Finance]
3/3
04:05 pm
npce
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
Low
Report
NeuroPace to Present at the Leerink Partners Global Healthcare Conference
3/3
07:26 am
npce
NeuroPace Inc (NPCE) Q4 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
High
Report
NeuroPace Inc (NPCE) Q4 2024 Earnings Report Preview: What to Look For [Yahoo! Finance]
2/21
06:26 am
npce
NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains? [Yahoo! Finance]
Medium
Report
NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains? [Yahoo! Finance]
2/20
04:05 pm
npce
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
Medium
Report
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
2/19
04:05 pm
npce
NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Medium
Report
NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
2/18
04:05 pm
npce
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
Medium
Report
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
2/14
07:06 am
npce
NeuroPace stock dips after pricing $65M share offering [Seeking Alpha]
High
Report
NeuroPace stock dips after pricing $65M share offering [Seeking Alpha]
2/14
06:33 am
npce
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
High
Report
NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock
2/13
06:07 pm
npce
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock [Yahoo! Finance]
High
Report
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock [Yahoo! Finance]
2/13
04:49 pm
npce
NeuroPace announces proposed public offering of $65M of common stock [Seeking Alpha]
High
Report
NeuroPace announces proposed public offering of $65M of common stock [Seeking Alpha]
2/13
04:34 pm
npce
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
Medium
Report
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
2/3
04:51 pm
npce
NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th [Yahoo! Finance]
Medium
Report
NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th [Yahoo! Finance]
2/3
04:05 pm
npce
NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th
Low
Report
NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th
1/30
06:42 pm
npce
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Wells Fargo & Company from $13.00 to $17.00. They now have an "overweight" rating on the stock.
Medium
Report
NeuroPace, Inc. (NASDAQ: NPCE) had its price target raised by analysts at Wells Fargo & Company from $13.00 to $17.00. They now have an "overweight" rating on the stock.
1/28
05:15 pm
npce
NeuroPace Issues 2025 Financial Guidance Targets
Medium
Report
NeuroPace Issues 2025 Financial Guidance Targets
1/21
08:02 am
npce
NeuroPace, Inc. (NASDAQ: NPCE) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.
Low
Report
NeuroPace, Inc. (NASDAQ: NPCE) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.
1/8
04:05 pm
npce
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates
Low
Report
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates